Cargando…

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events

Detalles Bibliográficos
Autores principales:	Kino, Aya, Choudhury, Lubna, Carr, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304970/ http://dx.doi.org/10.1186/1532-429X-14-S1-P165

Ejemplares similares

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Lower-than-normal myocardial stress and excess hypertrophy from CMR are associated with worsening ventricular contractile performance in hypertrophic cardiomyopathy
por: Zhong, Liang, et al.
Publicado: (2016)

The evolution and clinical importance of scar in hypertrophic cardiomyopathy - a 7 year CMR follow-up study
por: Quarta, Giovanni, et al.
Publicado: (2011)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

Relationship between CMR derived myocardial extracellular volume and myocardial replacement scarring in non-ischemic cardiomyopathy
por: Ghosn, Mohamad G, et al.
Publicado: (2014)

Non-contrast T1rho CMR for hypertrophic cardiomyopathy
por: Wang, Chunhua, et al.
Publicado: (2015)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

Size of myocardial fibrosis by LGE, pre- and post-contrast T1 and ECV in patients with hypertrophic cardiomyopathy referenced to normal appearing myocardium or healthy volunteers
por: Avanesov, Maxim, et al.
Publicado: (2015)

The use of cardiac magnetic resonance imaging in diagnosing and characterizing hypertrophic cardiomyopathy
por: Ogele, Emmanuel, et al.
Publicado: (2016)

Scar heterogeneity in hypertrophic cardiomyopathy. Comparison with chronic myocardial infarction and normal subjects
por: Vianello, Pier Filippo, et al.
Publicado: (2014)

Myocardial scar surface area identified by LGE MRI is an independent predictor of mortality in post-infarction patients
por: Tao, Qian, et al.
Publicado: (2015)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

LGE in pulmonary hypertension predicts clinical events
por: Soma, Siva, et al.
Publicado: (2011)

Presence of transmural posterolateral scar by LGE MRI is associated with non-response to CRT
por: Chan, Leslie, et al.
Publicado: (2011)

Dependence of scar contrast in LGE images on the time interval after contrast injection
por: Vijayakumar, Sathya, et al.
Publicado: (2011)

Change in scar visibility in LGE-MRI with time after RF ablation procedure
por: Kholmovski, Euguene, et al.
Publicado: (2015)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
por: van Hoorn, Frans, et al.
Publicado: (2012)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
por: Gommans, Frank, et al.
Publicado: (2012)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

cMR in acute myocardial infarction: correlation between myocardial scar and echocardiographic strain
por: Weissman, Gaby, et al.
Publicado: (2012)

Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart and hypertrophic cardiomyopathy
por: Sai, Eiryu, et al.
Publicado: (2015)

Ascending aorta flow derangement is a marker of outflow obstruction in hypertrophic cardiomyopathy
por: Allen, Bradley D, et al.
Publicado: (2014)

Delayed enhancement and myocardial velocity mapping CMR reveal differences in regional left ventricular function with varying levels of scar
por: Goyal, Amita, et al.
Publicado: (2013)

Maximal left ventricular wall thickness: a comparison between CMR and echocardiography in hypertrophic cardiomyopathy
por: Corona-Villalobos, Celia P, et al.
Publicado: (2013)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Myocardial strain in a health and disease: CMR feature tracking analysis in cardiac hypertrophy
por: Barison, Andrea, et al.
Publicado: (2013)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cs5uqvjb1sleolh6abe0vmgbmk